28 min ago | AmericanBankingNews.com
L-3 Communications Upgraded by Oppenheimer
The analysts wrote, "We had been Underperform on LLL for three reasons: its exposure to the Pentagon's Operations and Maintenance budget; its high percentage of services revenue ; and the short-cycle nature of its products, which make it immediately sensitive to downward DoD budgetary pressures.
Amdocs Limited's "Neutral" Rating Reaffirmed at Zacks
's stock had its "neutral" rating reaffirmed by Zacks in a research note issued on Monday.
Analyst Insights: Fresh Market, Air Methods, Threshold...
The Fresh Market, Inc. : Cowen previewed Q1 results for The Fresh Market which is scheduled to report May 30th and expects continued comp momentum, accelerating unit growth, and sees benefits from moderating food inflation trends.
CRT Capital Analysts Begin Coverage on ViaSat
The firm set a "fair value" rating on the stock. Other equities research analysts have also recently issued reports about the stock.
Cohen Breaks From GOP, Says Minimum Wage Should Be Tied To Aid For Small Businesses
Republican Senate candidate Bob Cohen today said he supports increasing the minimum wage in New York if it's tied to tax relief for small businesses.
Salesforce.com was upgraded today by Oppenheimer from perform to outperform with a price target of $180, as the company has been experiencing fast organic growth.
Makemytrip Limited PT Lowered to $19.00 at Deutsche Bank
The analysts wrote, "MakeMyTrip reported better than expected F4Q12 results on both the top and bottom line, driven by stronger than expected air take rates and strong core operating metrics.
Oppenheimer Gives Outperform Rating to General Electric
's stock had its "outperform" rating restated by equities researchers at Oppenheimer in a report issued on Thursday.
Must Know Stock Upgrades and Downgrades Today
Wall St. Watchdog reveals information about companies for which stock analysts either upgraded or downgraded the shares on May 24th.
Citigroup Downgrades Jiayuan.com to "Neutral"
Jiayuan.com traded down 2.60% on Thursday, hitting $3.74. Jiayuan.com has a 52-week low of $3.80 and a 52-week high of $16.12. The company has a market cap of $118.4 million and a price-to-earnings ratio of 32.27. Jiayuan.com last posted its quarterly earnings results on Wednesday, May 23rd.
Ituran Location and Control Ltd.
They currently have a $16.00 target price on the stock. Ituran Location and Control Ltd.
Salesforce.com Upgraded by Oppenheimer to "Outperform"
Other equities research analysts have also recently issued reports about the stock.
PrivateBancorp Given New $17.00 Price Target at JPMorgan Chase
The analysts wrote, "While near-term improvements to profitability will continue to be driven largely from credit-related costs, management is focused on improving ROA and ROE longer term and has even realigned incentives to drive towards greater profitability.
HeartWare Given "Buy" Rating at Canaccord Genuity
's stock had its "buy" rating reiterated by investment analysts at Canaccord Genuity in a note issued to investors on Thursday.
Oppenheimer Upgrades Retalix Ltd to "Outperform"
Shares of Retalix Ltd opened at 18.98 on Thursday. Retalix Ltd has a one year low of $11.63 and a one year high of $21.00. The company has a market cap of $465.0 million and a P/E ratio of 32.17. RTLX has been the subject of a number of other recent research reports.
Jefferies Group Analysts Begin Coverage on Express-1 Expedited
Shares of Express-1 Expedited opened at 16.35 on Thursday. Express-1 Expedited has a 52 week low of $6.61 and a 52 week high of $18.60. The company's market cap is $288.0 million.
Apple today had its estimates and price target lowered by Oppenheimber to $680 due to an inconsistent news flow.
Credit Suisse Analysts Initiate Coverage on Jazz Pharmaceuticals
Shares of Jazz Pharmaceuticals opened at 43.66 on Wednesday. Jazz Pharmaceuticals has a one year low of $26.17 and a one year high of $54.50. The company has a market cap of $2.477 billion and a P/E ratio of 16.65. Jazz Pharmaceuticals last issued its quarterly earnings data on Tuesday, May 8th.
Aastrom Biosciences Now Covered by Analysts at Needham & Company.
The firm set a "buy" rating on the stock. A number of other firms have also recently commented on ASTM.
Auxilium Pharma Upgraded by MKM Partners
The firm currently has a $21.00 target price on the stock, up from their previous target price of $20.00. Shares of Auxilium Pharma traded up 6.91% during mid-day trading on Tuesday, hitting $19.18. Auxilium Pharma has a 52 week low of $13.59 and a 52 week high of $24.88. The company's market cap is $926.5 million.